Skip to main content
. 2024 Apr 15;13(6):1055–1066. doi: 10.1002/psp4.13141

TABLE 2.

Summary of the exposure–efficacy analysis (N = 429): base models.

Endpoint Analysis type Number of patients with an event, n (%) p value
PFS CPH model 105 (25.4) 0.011
EFSeff 110 (25.6) 0.010
OS 51 (11.9) 0.117
CR at EOT Logistic regression 339 (79.0) 0.149

Abbreviations: CPH, Cox proportional hazards; CR, complete response; EFSeff, event‐free survival‐efficacy; EOT, end of treatment; OS, overall survival; PFS, progression‐free survival.